INtRON Biotechnology (Korea) Alpha and Beta Analysis

048530 Stock  KRW 5,630  20.00  0.36%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as iNtRON Biotechnology. It also helps investors analyze the systematic and unsystematic risks associated with investing in INtRON Biotechnology over a specified time horizon. Remember, high INtRON Biotechnology's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to INtRON Biotechnology's market risk premium analysis include:
Beta
0.21
Alpha
(0.25)
Risk
1.88
Sharpe Ratio
(0.07)
Expected Return
(0.13)
Please note that although INtRON Biotechnology alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, INtRON Biotechnology did 0.25  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of iNtRON Biotechnology stock's relative risk over its benchmark. iNtRON Biotechnology has a beta of 0.21  . As returns on the market increase, INtRON Biotechnology's returns are expected to increase less than the market. However, during the bear market, the loss of holding INtRON Biotechnology is expected to be smaller as well. .
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out INtRON Biotechnology Backtesting, INtRON Biotechnology Valuation, INtRON Biotechnology Correlation, INtRON Biotechnology Hype Analysis, INtRON Biotechnology Volatility, INtRON Biotechnology History and analyze INtRON Biotechnology Performance.

INtRON Biotechnology Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. INtRON Biotechnology market risk premium is the additional return an investor will receive from holding INtRON Biotechnology long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in INtRON Biotechnology. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate INtRON Biotechnology's performance over market.
α-0.25   β0.21

INtRON Biotechnology expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of INtRON Biotechnology's Buy-and-hold return. Our buy-and-hold chart shows how INtRON Biotechnology performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

INtRON Biotechnology Market Price Analysis

Market price analysis indicators help investors to evaluate how INtRON Biotechnology stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading INtRON Biotechnology shares will generate the highest return on investment. By understating and applying INtRON Biotechnology stock market price indicators, traders can identify INtRON Biotechnology position entry and exit signals to maximize returns.

INtRON Biotechnology Return and Market Media

The median price of INtRON Biotechnology for the period between Thu, Aug 29, 2024 and Wed, Nov 27, 2024 is 5880.0 with a coefficient of variation of 5.16. The daily time series for the period is distributed with a sample standard deviation of 307.82, arithmetic mean of 5966.36, and mean deviation of 224.38. The Stock did not receive any noticable media coverage during the period.
 Price Growth (%)  
       Timeline  

About INtRON Biotechnology Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including INtRON or other stocks. Alpha measures the amount that position in iNtRON Biotechnology has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards INtRON Biotechnology in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, INtRON Biotechnology's short interest history, or implied volatility extrapolated from INtRON Biotechnology options trading.

Build Portfolio with INtRON Biotechnology

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Other Information on Investing in INtRON Stock

INtRON Biotechnology financial ratios help investors to determine whether INtRON Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in INtRON with respect to the benefits of owning INtRON Biotechnology security.